VivoSeq
Other

In Vitro Fertilization (IVF)

0

Pipeline Programs↗

1

Active Trials↗

1

Companies Involved↗

In Vitro Fertilization (IVF) is an early-stage landscape with 0 programs across 1 company. The most active players are Merck & Co..

Intelligence

Pipeline Metrics

Competitive Density

6/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

69/100

Attrition Rate

28/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Merck & Co. logo

Merck & Co.

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

18

clinical trials

Completed11 · 61%
Terminated4 · 22%
Withdrawn1 · 6%
Not yet recruiting1 · 6%
Unknown status1 · 6%

Clinical Trials

Trial Activity

18 trials

Optimal Stimulation of Hypo-responders Undergoing in Vitro Fertilization (IVF)
Not yet recruiting·DDunamenti REK Istenhegyi IVF Center·Phase 4·NCT07121751·150 enrolled
Ovarian Response Prediction in In Vitro Fertilization (IVF) Patients
Completed·UUniversity Hospital Schleswig-Holstein·N/A·NCT01206803·294 enrolled
Safety and Efficacy of Pre-defined, Fixed Dose of Gonal-f Pen Based on Subject Baseline Characteristics in Subjects Undergoing in Vitro Fertilization (IVF)
Completed·Merck & Co. logoMerck & Co.·Phase 4·NCT00249834·166 enrolled
Metformin Treatment Before in Vitro Fertilization (IVF) in Women With Ultrasound Evidence of Polycystic Ovaries
Completed·UUniversity of Oxford·N/A·NCT01046032·134 enrolled
Human Chorionic Gonadotropin (hCG) Priming Prior to Controlled Ovarian Hyperstimulation (COH) in Poor Responder In Vitro Fertilization (IVF) Patients
Completed·IIVI Madrid·Phase 4·NCT00870025·60 enrolled
Poor Ovarian Stimulation Response in In Vitro Fertilization (IVF) Program
Completed·—·Phase 1·NCT02640976·216 enrolled
Use of Atosiban in in Vitro Fertilization (IVF) Treatment
Completed·TThe University of Hong Kong·Phase 4·NCT01501214·800 enrolled
Administration of Follicle-stimulating Hormone (FSH) and Low Dose Human Chorionic Gonadotropin (hCG) for Oocyte Maturity While Decreasing hCG Exposure in In Vitro Fertilization (IVF) Cycles
Completed·UUniversity of California, San Francisco·Phase 3·NCT02310919·105 enrolled
Subcutaneous Progesterone Versus Vaginal Progesterone Tablets for Luteal Phase Support in In Vitro Fertilization (IVF)
Completed·IIBSA Institut Biochimique SA·Phase 3·NCT00828191·800 enrolled
Comparison of Crinone 8% Intravaginal Gel and IM Progesterone Supplementation for In Vitro Fertilization (IVF)
Completed·—·Phase 4·NCT00656201·468 enrolled
A Multicentre, Randomised, Double-blind, Placebo-controlled Proof of Concept Study to Compare the Efficacy and Safety of r-hLIF (Emfilermin) for Improving Embryo Implantation Following in Vitro Fertilization (IVF) and Embryo Transfer (ET) in Women With Recurrent Implantation Failure
Completed·Merck & Co. logoMerck & Co.·Phase 1/2·NCT00504608·150 enrolled
Working IVF Patients' Quality of Life
Completed·UUniversity Hospital, Montpellier·N/A·NCT04966091·200 enrolled
Protocols for Improved in Vitro Fertilization (IVF) Outcomes
Terminated·UUniversity of California, San Francisco·Phase 4·NCT00334243·2 enrolled
A Study of the Effects of a Novel Ovarian Stimulation Regimen on Embryo Aneuploidy Rates in In Vitro Fertilization (IVF)
Terminated·BBart CJM Fauser·Phase 4·NCT00866008·34 enrolled
The Impact of Treating Minor Uterine Cavity Abnormalities Diagnosed by Office Hysteroscopy in Unselected In Vitro Fertilization (IVF) Cases
Terminated·UUMC Utrecht·Phase 2·NCT00830401·700 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)